查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球凍乾/冷凍乾燥設備市場-2022-2029
市場調查報告書
商品編碼
1146450

全球凍乾/冷凍乾燥設備市場-2022-2029

Global Lyophilization/Freeze Drying Equipment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

冷凍乾燥/冷凍乾燥設備的全球市場規模預計在預測期內（2022-2029 年）將以 8.1% 的複合年增長率增長。

冷凍乾燥機或凍乾機從樣品中去除水或其他溶劑，使冰直接從固體變為蒸氣，而無需通過液相。冷凍乾燥以各種能力完成，從小型家用冷凍乾燥機（用於冷凍乾燥食品）到大型生產規模的設備。實驗室冷凍乾燥機通常用於生物和環境研究以及幾種先進藥物的開發。

市場動態

全球冷凍乾燥/冷凍乾燥設備市場的增長受到技術進步、對冷凍乾燥產品和醃製食品的需求增加以及生命科學領域研發活動增加的推動。

冷凍乾燥工藝優勢的增加推動市場增長

製藥和生物技術行業不斷增加的研發活動正在推動市場發展。根據 2021 年 11 月發表在《國際藥劑學雜誌》上的一篇文章，腸外生物藥物以液體或固體產品的形式銷售，這些產品是通過各種填充和完成技術製造的。大約 34% 的生物製藥在歐洲市場以凍乾產品的形式出售，這使得通過凍乾脫水成為製造固體生物製藥的黃金標準。冷凍乾燥被認為具有幾個優點。冷凍乾燥可提高對熱敏感和易腐爛的生物藥品的保質期，並減少對冷鏈的需求。加工過程中的極低溫度限制了化學分解，加工後的低殘留水分 (RMC) 使產品保持穩定。

2022年7月，NJM推出了適用於研發實驗室和商業灌裝包裝線的Dara Coolvacuum凍乾設備。該儀器採用符合 FDA 21 CFR 第 11 部分的 Scada 軟件設計，可滿足 FDA GAMP5 和 GMP 規定。同樣在 2020 年，Coolvavuum 成為 Dara Pharma Group 的一部分，使 Dara 成為凍乾注射劑交鑰匙解決方案的全球製造商。

與冷凍乾燥工藝相關的缺點阻礙市場增長

然而，傳統的冷凍乾燥工藝有一些缺點。處理時間從幾天到幾週不等，高昂的資本成本和能源消耗降低了整個過程的效率。如果過程失敗，靜態過程也會增加整個批次被拒絕的風險。批處理僅限於處理小單位劑量並且需要許多小瓶。儘管目前有良好的生產規範 (cGMP)，但在該過程中的人為乾預會增加污染的風險。此外，還存在有關乾燥器設計、容器密封性、負載條件、取決於產品配方的傳熱和傳質以及工藝放大的問題。

COVID-19 影響分析

針對 COVID-19 的疫苗和 PCR 診斷試劑盒對於抗擊這一流行病至關重要。與其儲存、運輸和使用相關的最大挑戰之一是需要冷藏或冷凍材料。凍乾在開發均勻可靠的藥物化合物方面發揮著重要作用。根據 Hudson Valeriomac 的說法，冷凍乾燥可以穩定藥物，並能夠工業化生產用於壓片和封裝的粉末。製藥客戶使用冷凍乾燥來製造保質期長的產品，例如疫苗和其他注射劑。 COVID-19 增加了對凍乾產品的需求，並增加了全球對凍乾設備的需求。

最近，批量冷凍乾燥是大多數生物製藥產品的現代乾燥技術。多種替代乾燥技術越來越多地為製造固體生物藥物提供了廣闊的前景，同時又不影響其安全性、質量和功效。這些潛在的干燥技術不僅將減少製造救生藥物所涉及的時間、能源消耗和相關成本，而且還有助於生物製藥行業降低 COVID-19 期間與藥物供應相關的任何風險。

細分分析

在預測期內（2022-2029 年），研究部門預計將以最快的複合年增長率增長。

研究部門佔據了最大的市場份額。近年來，生物製藥已成為改善各種自身免疫性疾病、癌症和遺傳疾病患者生活質量的突破性工具。隨著對生物製藥的需求不斷增長，必須在不影響產品安全性、質量和功效的情況下降低製造成本。凍乾用於生產固體生物藥物。

冷凍乾燥機具有以下優點：冷凍乾燥易碎、不穩定或熱敏感的藥物和生物製劑可以在低溫下乾燥，而不會影響其物理結構。凍乾產品可以快速輕鬆地複原。這對於需要盡快接種的緊急疫苗和抗體尤其有價值。

根據 2022 年 8 月發表在 Advanced Drug Delivery Reviews 上的一篇論文，當不需要特定生物化合物的液體穩定性時，凍乾或冷凍產品開發是配方設計師的最佳選擇。這將是一種可能的情況。例如，凍乾活病毒疫苗（LVV）的開發。

此外，市場參與者正在設計用於研究目的的冷凍乾燥機。例如，VertMarkets Inc. 提供全面可靠的冷凍乾燥解決方案，旨在滿足工業和學術研發設施不斷增長的需求。

區域分析

亞太地區在全球冷凍乾燥/冷凍乾燥設備市場中佔有最大的市場份額。

亞太地區在冷凍乾燥/冷凍乾燥設備市場佔據主導地位，預計在預測期內將呈現類似趨勢。市場增長的背後是對生物技術行業研發投資的增加、對凍乾產品的需求不斷增長、技術進步以及亞太地區主要參與者的存在。

用於生物技術行業研究的資金不斷增加正在推動市場。例如，2022 年 7 月，MaxHealth Biotechnology 以 7400 萬美元的 B 輪融資位居亞太私營生物技術投資集團之首。該組織將利用這筆資金擴大針對大流行性流感、季節性流感、狂犬病和冠狀病毒等傳染病的疫苗開發。

此外，食品行業在該地區佔據主導地位。對即食食品的需求推動了亞太地區的冷凍乾燥/冷凍乾燥設備市場。例如，2021 年 6 月，日本可口可樂推出了速溶啤酒凍乾大麥茶、咖啡塊和綠茶。冷凍乾燥可以將茶葉和咖啡豆的原始香氣和風味濃縮成立方體，提供美味的杯子，非常適合外出時打包或在家中少洗漱享用。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 對凍乾類型的需求不斷增長
      • 冷凍乾燥技術的技術進步
    • 限制因素
    • 缺乏熟練工人
    • 商機
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 製冷系統
  • 真空系統
  • 控制和監控系統
  • 產品室/歧管
  • 就地清洗 (CIP) 系統
  • 烘乾室
  • 裝卸系統
  • 其他設備

第 8 章技術

  • 托盤式冷凍乾燥機
  • 歧管冷凍乾燥機
  • 旋轉式冷凍乾燥機

第 9 章按經營規模

  • 實驗室規模冷凍乾燥機
  • 中試規模冷凍乾燥機
  • 工業冷凍乾燥機

第 10 章按應用程序

  • 營養保健品
  • 藥物開發
  • 醫學診斷
  • 調查研究
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Millrock Technology Inc.
  • SP Scientific
  • Zirbus Technology GmbH
  • Azbil Telstar SL
  • LTE Scientific
  • Biopharma Process Systems Ltd.
  • GEA Group
  • Martin Christ GmbH
  • Cuddon Freeze Dry

第 14 章全球冷凍乾燥機市場DataM

簡介目錄
Product Code: DMMD1110

Market Overview

The global lyophilization/freeze drying equipment market size was growing at a CAGR of 8.1% during the forecast period (2022-2029).

Freeze drying or lyophilization equipment removes water or other solvents from the sample, allowing the ice to change directly from a solid to a vapor without passing through a liquid phase. Lyophilization is achieved in various volumes, from small at-home (to freeze-dry foods) freeze dryers to large, production-scale equipment. Laboratory freeze dryers are generally used for research in biological and environmental disciplines and in developing multiple advanced medicines.

Market Dynamics

The growth of the global lyophilization/freeze drying equipment market is driven by technological advancements, increasing demand for lyophilized products and preserved food and rising research and development activities in life sciences.

An increasing advantage of freeze drying process drives the market growth

The increasing number of research and development activities in the pharmaceutical and biotechnology industries drives the market. As per the article published in the International Journal of Pharmaceutics in November 2021, Parenteral biopharmaceuticals are marketed as liquid or solid products manufactured by various fill finish technologies. With about 34 % of biopharmaceuticals marketed as freeze-dried products in the European market, dehydration via freeze-drying is the gold standard for manufacturing solid biopharmaceuticals. Several advantages of Freeze-drying have been recognized. Freeze-drying allows improved shelf-life of heat-sensitive and labile biopharmaceuticals and reduces the requirement for a cold chain. Chemical decomposition is reduced at very low temperatures during the process, with low residual moisture content (RMC) post-processing, keeping the product stable.

In July 2022, NJM launched Dara coolavacuum freeze-drying equipment, suitable for research and development laboratory and commercial fill-finish packaging lines. This equipment is designed with Scada software for FDA 21 CFR part 11 compliance to meet FDA GAMP5 and GMP regulations. Also, In 2020, Coolvavuum became part of the Dara Pharma Group, and Dara has become a global manufacturer capable of offering turn-key solutions for freeze-dried injectable drugs.

The drawbacks related to freeze drying process will hamper the growth of the market

However, several drawbacks are associated with the conventional freeze-drying process. Processing times could vary from days to weeks, with high capital costs and energy consumption leading to reduced efficiency in the overall process. Also, a static process increases the risk of rejection of the entire batch in case of process failure. A batch process is limited to processing small volumes of unit doses, increasing the requirement for many vials. Human intervention during the process can increase the risk of contamination despite current Good Manufacturing Practices (cGMP). In addition, concerns related to heat and mass transfer and scaling up the process, which depend on the dryer design, container closure, load condition and product formulation.

COVID-19 Impact Analysis

Vaccines and PCR diagnostic kits for COVID-19 are crucial for fighting the pandemic. One of the largest challenges associated with their storage, transport and use is the requirement for refrigeration or freezing of the material. Lyophilization, or freeze-drying, recreates a key role to play in developing pharmaceutical compounds that are both uniform and reliable. According to Hudson Valley Lyomac organization, freeze-drying stabilizes medicines and allows the industrial production of powders for tableting or encapsulating. Pharmaceutical customers utilize freeze-drying to create products with long shelf life, including vaccines or other injected medications. COVID-19 exclusively increases the demand for lyophilization products and increases the demand for freeze-drying equipment worldwide.

Recently, batch freeze-drying is a modern drying technology for the most biopharmaceutical products. Multiple alternative drying technologies have increasingly offered promising prospects for manufacturing solid biopharmaceuticals without compromising biopharmaceutical products' safety, quality and efficacy. These potential drying technologies are significant to the biopharmaceutical industry as they will not only reduce time, energy consumption and associated costs with the manufacturing of life-saving drugs but also help mitigate any risks with the supply of drugs during COVID-19.

Segment Analysis

The research segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The research segment accounts for the largest market share. In recent years, biopharmaceuticals have been a breakthrough in enhancing the quality of lives of patients with various autoimmune, cancers, and genetic disorders. With the rising demand for biopharmaceuticals, the need to reduce manufacturing costs is essential without compromising product safety, quality, and efficacy. Freeze-drying is used in the manufacturing of solid biopharmaceuticals.

Freeze dryers provide the advantages such as With freeze drying. Delicate, unstable or heat-sensitive drugs and biologicals can be dried at low temperatures without damaging their physical structure. Freeze-dried products can be reconstituted quickly and easily, which is particularly valuable in the case of emergency vaccines and antibodies, which need to be administered as quickly as possible.

As per the article published in Advanced Drug Delivery Reviews in August 2022, if the liquid stability of a specific biological compound is not desirable, the development of a freeze-dried or frozen product will be the most likely scenario to be followed by formulators. For instance, developing freeze-dried live virus vaccines (LVV).

In addition, the market players are designing freeze dryers for research purposes. For instance, VertMarkets Inc. provides trusted, freeze-drying solutions designed to meet the increasing demands of R&D facilities in industry and academia with a comprehensive equipment range.

Geographical Analysis

Asia Pacific region holds the largest market share of the global lyophilization/freeze drying equipment market

The Asia Pacific dominates the lyophilization/freeze-drying equipment market and is expected to show a similar trend over the forecast period. The market's growth can be attributed to increasing investment in research and development in biotech industries, increasing demand for freeze-dried products, technological advancement, and key players in the Asia Pacific region.

The rising funding for research in biotechnological industries drives the market. For instance, in July 2022, MaxHealth Biotechnology reigned supreme in the Asia-Pacific region's private biotech investment sphere with a $74 million Series B round. The organization will utilize this funding to expand the development of vaccines for infectious diseases, including pandemic influenza, seasonal influenza, rabies and coronavirus.

In addition, the food sector is dominating in the region. The demand for ready-to-use food drives the market for freeze-drying equipment in the Asia Pacific region. For instance, in June 2021, Coca-Cola Japan launched freeze-dried barley tea, coffee cubes, and green tea for instant brews. Freeze drying helps concentrate the original aroma and flavor of tea leaves and coffee beans into the cube for a flavorful brew perfect for packing for excursions or only enjoying at residence with less washing.

Competitive Landscape

The lyophilization/freeze-drying equipment market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Thermo Fisher Scientific Inc., Millrock Technology Inc., SP Scientific, Zirbus Technology GmbH, Azbil Telstar SL, LTE Scientific, Biopharma Process Systems Ltd., GEA Group, Martin Christ GmbH, and Cuddon Freeze Dry, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global lyophilization/freeze-drying equipment market.

For instance,

  • In March 2020, Telstar developed a novel laboratory freeze dryer, LyoQuest Arctic operating with natural gases, particularly designed for research and development laboratories. It is a bench-top, environmentally friendly lab freeze-dryer. Unlike conventional freeze dryers operating HFC cooling gases, the Lyoquest Arctic decreases the GWP impact more than 1,000-fold.

Millrock Technology, Inc.

Overview:

Millrock Technology is an innovator in advanced freeze-dryer technology for pharmaceutical, biotechnology, diagnostics, and life science applications. It offers a pharmaceutical quality (c-GMP) freeze dryer or a production freeze dryer for the life sciences. Each production freeze dryer is custom designed and manufactured to meet the user's specific application and is cost-effective.

Product Portfolio:

QuantaS Steam Sterilizable Production Freeze Dryer: The QuantaS Steam Sterilizable Production Freeze Dryer supplies cGMP pharmaceutical freeze dryers with 21CFR part 11 and steam sterilization (SIP) for requesting applications in bio-pharmaceutical and pharmaceutical applications.

The global lyophilization/freeze drying equipment market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising demand for lyophilized Types
      • 4.1.1.2. Technological Advancements in lyophilization technique
    • 4.1.2. Restraints:
    • 4.1.3. Lack of skilled workforce
    • 4.1.4. Opportunity
    • 4.1.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Refrigeration System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Vacuum System
  • 7.4. Controlling and Monitoring Systems
  • 7.5. Product Chamber or Manifold
  • 7.6. Clean-In-Place (CIP) Systems
  • 7.7. Drying Chambers
  • 7.8. Loading and Unloading Systems
  • 7.9. Other Equipment

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Tray style Freeze Dryers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Manifold Freeze Dryer
  • 8.4. Rotatory Freeze Dryers

9. By Scale of Operation

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 9.1.2. Market Attractiveness Index, By Scale of Operation
  • 9.2. Lab-Scale Freeze Dryers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pilot-Scale Freeze Dryers
  • 9.4. Industrial-Scale Freeze Dryers

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Nutraceuticals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Drug Development
  • 10.4. Medical Diagnostics
  • 10.5. Research
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Scale of Operation
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Thermo Fisher Scientific Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Millrock Technology Inc.
  • 13.3. SP Scientific
  • 13.4. Zirbus Technology GmbH
  • 13.5. Azbil Telstar SL
  • 13.6. LTE Scientific
  • 13.7. Biopharma Process Systems Ltd.
  • 13.8. GEA Group
  • 13.9. Martin Christ GmbH
  • 13.10. Cuddon Freeze Dry

LIST NOT EXHAUSTIVE

14. Global Lyophilization/Freeze Drying Equipment Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us